Romosozumab 105mg/1.17ml solution for injection pre-filled disposable devices
NHS hospitals in England used £19,498,002 of indicative cost of Romosozumab 105mg/1.17ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 31.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Romosozumab 105mg/1.17ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Romosozumab 105mg/1.17ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £897,004 |
| Cambridge Univ Hosp Nhs Foundation Trust | £630,514 |
| Robert Jones & Agnes Hunt Hpl Nhs Trust | £615,969 |
| South Tees Hosp Nhs Foundation Trust | £565,067 |
| East Sussex Healthcare Nhs Trust | £475,666 |
| Imperial College Healthcare Nhs Trust | £453,422 |
| Luton & Dunstable Hospital Trust | £442,087 |
| Gateshead Health Nhs Foundation Trust | £432,889 |
| Somerset P/Ship Nhs Foundation Trust | £432,248 |
| Leeds Teaching Hpls Nhs Trust | £418,774 |
The primary-care picture
Romosozumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Romosozumab medicine page.